共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R023056-2mg | 2mg | 5~7个工作日 |
Ki16425 Ki16425 |
99% |
|
|
罗恩 | R023056-5mg | 5mg | 5~7个工作日 |
Ki16425 Ki16425 |
99% |
|
|
罗恩 | R023056-25mg | 25mg | 5~7个工作日 |
Ki16425 Ki16425 |
99% |
|
|
阿拉丁 | K126742-5mg | 5mg | 现货 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
Moligand™, ≥98% |
|
|
阿拉丁 | K126742-25mg | 25mg | 现货 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
Moligand™, ≥98% |
|
|
阿拉丁 | K126742-1mg | 1mg | 现货 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
Moligand™, ≥98% |
|
|
阿拉丁 | K126742-100mg | 100mg | 现货 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
Moligand™, ≥98% |
|
|
阿拉丁 | K423594-1ml | 1ml | 现货 |
Ki16425 Ki16425 |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ00C1WR-5mg | 5mg | 期货,请咨询 |
Ki 16425; 3-[[[4-[4-[[[1-(2-... Ki16425 |
98+% |
|
|
凯为 | JZ00C1WR-10mg | 10mg | 期货,请咨询 |
Ki 16425; 3-[[[4-[4-[[[1-(2-... Ki16425 |
98+% |
|
|
毕得 | BD210766-5mg | 5mg | 现货 |
3-((4-(4-(((1-(2-氯苯基)乙氧基)羰基)... 3-((4-(4-(((1-(2-Chloropheny... |
98+% |
|
|
毕得 | BD210766-10mg | 10mg | 现货 |
3-((4-(4-(((1-(2-氯苯基)乙氧基)羰基)... 3-((4-(4-(((1-(2-Chloropheny... |
98+% |
|
|
毕得 | BD210766-50mg | 50mg | 现货 |
3-((4-(4-(((1-(2-氯苯基)乙氧基)羰基)... 3-((4-(4-(((1-(2-Chloropheny... |
98+% |
|
|
百灵威 | JK618774-25MG | 25MG | 4-6周 |
Ki 16425, 竞争性可逆LPA拮抗剂 Ki 16425, 98%, competitive, ... |
98% |
|
|
Sigma | SML0971-5MG | 5mg | 请咨询 |
(-20°C)Ki 16425 Ki 16425 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
Sigma | SML0971-25MG | 25mg | 请咨询 |
(-20°C)Ki 16425 Ki 16425 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
源叶 | S80674-5mg | 5mg | 期货,请咨询 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
≥98% |
|
|
源叶 | S80674-1mg | 1mg | 期货,请咨询 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
≥98% |
|
|
源叶 | S80674-25mg | 25mg | 期货,请咨询 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
≥98% |
|
|
源叶 | S80674-100mg | 100mg | 期货,请咨询 |
Ki16425,LPA1和LPA3受体拮抗剂 Ki16425 |
≥98% |
|
|
源叶 | T98087-1ml | 1ml | 期货,请咨询 |
Ki16425 Ki16425 |
10mM in DMSO |
|
|
Target Mol | T6108-1mg | 1mg | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Target Mol | T6108-5mg | 5mg | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Target Mol | T6108-10mg | 10mg | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Target Mol | T6108-25mg | 25mg | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Target Mol | T6108-50mg | 50mg | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Target Mol | T6108-100mg | 100mg | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Target Mol | T6108-200mg | 200mg | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Target Mol | T6108-1mL | 1mL | 现货 |
化合物 Ki16425 Ki16425 |
97.78% |
|
|
Echelon | B-0730-5mg | 5mg | 49天 |
Ki16425 (LPA Receptor Antago... Ki16425 (LPA Receptor Antago... |
|
|
|
Echelon | B-0730-10mg | 10mg | 49天 |
Ki16425 (LPA Receptor Antago... Ki16425 (LPA Receptor Antago... |
|
|
|
Echelon | B-0730-50mg | 50mg | 49天 |
Ki16425 (LPA Receptor Antago... Ki16425 (LPA Receptor Antago... |
|
|
|
Am | A114375-50mg | 50mg | 现货 |
Ki16425 Ki16425 |
98+% |
|
|
Am | A114375-10mg | 10mg | 现货 |
Ki16425 Ki16425 |
98+% |
|
|
Am | A114375-1mg | 1mg | 现货 |
Ki16425 Ki16425 |
98+% |
|
|
Am | A114375-5mg | 5mg | 现货 |
Ki16425 Ki16425 |
98+% |
|
|
MCE | HY-13285-50mg | 50mg | 现货 |
Ki16425 Ki16425 |
98.11% |
|
|
MCE | HY-13285-10mg | 10mg | 现货 |
Ki16425 Ki16425 |
98.11% |
|
|
MCE | HY-13285-10mM*1mL | 10mM*1mL | 现货 |
Ki16425 Ki16425 |
98.11% |
|
|
MCE | HY-13285-5mg | 5mg | 现货 |
Ki16425 Ki16425 |
98.11% |
|
|
MCE | HY-13285-1mg | 1mg | 现货 |
Ki16425 Ki16425 |
98.11% |
|
|